Page last updated: 2024-09-04

docetaxel anhydrous and Age-Related Memory Disorders

docetaxel anhydrous has been researched along with Age-Related Memory Disorders in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, J; Chow, LW; Liu, Q; Loo, WT; Ng, EL; Wang, M; Yip, MC	1
Callaghan, CK; O'Mara, SM	1
Abraham, J; Alkhouri, N; Haut, MW; Swayampakula, AK	1

Reviews

1 review(s) available for docetaxel anhydrous and Age-Related Memory Disorders

Article	Year
Cognitive impairment with significant brain parenchymal volume loss following standard adjuvant chemotherapy in a patient with breast cancer. Clinical advances in hematology & oncology : H&O, 2007, Volume: 5, Issue:12 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal; Cyclophosphamide; Dementia; Docetaxel; Doxorubicin; Female; Humans; Magnetic Resonance Imaging; Mastectomy, Segmental; Memory Disorders; Middle Aged; Taxoids	2007

Article

Year

Cognitive impairment with significant brain parenchymal volume loss following standard adjuvant chemotherapy in a patient with breast cancer.

Clinical advances in hematology & oncology : H&O, 2007, Volume: 5, Issue:12

Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal; Cyclophosphamide; Dementia; Docetaxel; Doxorubicin; Female; Humans; Magnetic Resonance Imaging; Mastectomy, Segmental; Memory Disorders; Middle Aged; Taxoids

2007

Other Studies

2 other study(ies) available for docetaxel anhydrous and Age-Related Memory Disorders

Article	Year
A pilot study: application of hemoglobin and cortisol levels, and a memory test to evaluate the quality of life of breast cancer patients on chemotherapy. The International journal of biological markers, 2013, Dec-17, Volume: 28, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Cyclophosphamide; Docetaxel; Erythrocyte Count; Female; Hemoglobins; Humans; Hydrocortisone; Leukocyte Count; Memory Disorders; Pilot Projects; Quality of Life; Surveys and Questionnaires; Taxoids; Treatment Outcome; Young Adult	2013
Long-term cognitive dysfunction in the rat following docetaxel treatment is ameliorated by the phosphodiesterase-4 inhibitor, rolipram. Behavioural brain research, 2015, Sep-01, Volume: 290 Topics: Animals; Antineoplastic Agents; Behavior, Animal; Cyclic Nucleotide Phosphodiesterases, Type 4; Depression; Disease Models, Animal; Docetaxel; Male; Memory Disorders; Phosphodiesterase 4 Inhibitors; Rats; Rats, Wistar; Rolipram; Spatial Memory; Taxoids	2015

Article

Year

A pilot study: application of hemoglobin and cortisol levels, and a memory test to evaluate the quality of life of breast cancer patients on chemotherapy.

The International journal of biological markers, 2013, Dec-17, Volume: 28, Issue:4

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Cyclophosphamide; Docetaxel; Erythrocyte Count; Female; Hemoglobins; Humans; Hydrocortisone; Leukocyte Count; Memory Disorders; Pilot Projects; Quality of Life; Surveys and Questionnaires; Taxoids; Treatment Outcome; Young Adult

2013

Long-term cognitive dysfunction in the rat following docetaxel treatment is ameliorated by the phosphodiesterase-4 inhibitor, rolipram.

Behavioural brain research, 2015, Sep-01, Volume: 290

Topics: Animals; Antineoplastic Agents; Behavior, Animal; Cyclic Nucleotide Phosphodiesterases, Type 4; Depression; Disease Models, Animal; Docetaxel; Male; Memory Disorders; Phosphodiesterase 4 Inhibitors; Rats; Rats, Wistar; Rolipram; Spatial Memory; Taxoids

2015